Home › Funds › COMMERZBANK AKTIENGESELLSCHAFT /FI › JNJ

COMMERZBANK AKTIENGESELLSCHAFT /FI position in JNJ

JOHNSON & JOHNSON · Health Care

COMMERZBANK AKTIENGESELLSCHAFT /FI reported holding 684,851 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$181.3M, representing 3.37% of its reported portfolio and ranking #4 among its reported holdings. COMMERZBANK AKTIENGESELLSCHAFT /FI has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)684.85K sh
Reported value held$181.31M
Portfolio Weight3.37%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How COMMERZBANK AKTIENGESELLSCHAFT /FI's JNJ position evolved

COMMERZBANK AKTIENGESELLSCHAFT /FI first disclosed a stake in JNJ in Q3 2023 at 826,591 shares (US$128.7M). The position peaked in Q4 2025 at 889,390 shares, worth US$184.1M. Across 13 filings, COMMERZBANK AKTIENGESELLSCHAFT /FI increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 684,851 shares valued at US$181.3M — an increase of 54,570 shares quarter over quarter.. Notable position changes include a 33% trim in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 826.59K $128.74M New
Q4 2023 829.73K $130.05M Hold
Q1 2024 860.99K $136.20M Add
Q2 2024 878.40K $128.39M Add
Q3 2024 997.91K $161.72M Add
Q4 2024 1.08M $155.62M Add
Q1 2025 969.15K $160.72M Reduce
Q2 2025 840.16K $128.33M Reduce
Q3 2025 856.75K $158.86M Add
Q4 2025 889.39K $184.06M Add
Q1 2026 595.31K $145.52M Reduce
Q2 2026 630.28K $160.07M Add
Q3 2026 684.85K $181.31M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has COMMERZBANK AKTIENGESELLSCHAFT /FI held JNJ?

COMMERZBANK AKTIENGESELLSCHAFT /FI has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is COMMERZBANK AKTIENGESELLSCHAFT /FI's current position in JNJ?

As of Q3 2026, COMMERZBANK AKTIENGESELLSCHAFT /FI holds 684.85K shares of JNJ (JOHNSON & JOHNSON), valued at $181.31M, representing 3.37% of its reported portfolio and ranking #4.

Has COMMERZBANK AKTIENGESELLSCHAFT /FI been buying or selling JNJ?

In the latest 13F filing (Q3 2026), COMMERZBANK AKTIENGESELLSCHAFT /FI increased its position in JNJ. The position peaked in Q4 2025 at 889.39K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.